跳至主要内容
临床试验/ISRCTN40495811
ISRCTN40495811进行中(未招募)1 期

Phase I Trial: RD 785.35736 (ADR-UK-23-1)

Theravia0 个研究点目标入组 90 人开始时间: 2024年4月12日最近更新:

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
Theravia
入组人数
90

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • The Health Research Authority (HRA) has approved deferral of publication of the full details of the trial. The full details will be added to the study record within 30 months after the trial has ended.

排除标准

  • The Health Research Authority (HRA) has approved deferral of publication of the full details of the trial. The full details will be added to the study record within 30 months after the trial has ended.

研究者

发起方
Theravia

相似试验

Phase I Trial: RD 785.35736 (ADR-UK-23-1) | 临床试验